Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-weekly Cetuximab + FOLFOX-6 in mCRC
NCT01051167Phase 2Completed
- Start
- Feb 2009
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of KL-140 in metastatic colorectal cancer (mCRC). Primary endpoint: Objective Response Rate. Started Feb 2009; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01051167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051167.